Nuvalent, Inc. (NUVL) intrinsic value & 10-year financials
Nuvalent, Inc. (NUVL) has no Graham intrinsic value right now because the formula needs positive earnings.
- Graham intrinsic value
- —
- Revenue (FY2025)
- —
- ROIC (10-yr avg)
- -15.5%
- Free cash flow (FY2025)
- —
NUVL 10-year financial history
| Fiscal year | Revenue | Net income | EPS (diluted) | Free cash flow | Operating margin | ROIC |
|---|---|---|---|---|---|---|
| FY2025 | — | -$425.4M | -$5.85 | — | — | -35.7% |
| FY2024 | — | -$260.8M | -$3.93 | — | — | -31.7% |
| FY2023 | — | -$126.2M | -$2.17 | — | — | -25.7% |
| FY2022 | — | -$81.9M | -$1.65 | — | — | -23.0% |
| FY2021 | — | -$46.3M | -$2.13 | — | — | -36.5% |
| FY2020 | — | -$14.6M | -$5.08 | — | — | 59.9% |
| FY2019 | — | — | — | — | — | — |
Source: annual 10-K filings on SEC EDGAR. Figures in USD.
Executive summary
Nuvalent, Inc. revenue growth over the past decade is N/A; insufficient history prevents a reliable 10-year CAGR calculation.
Nuvalent, Inc. has historically struggled to out-earn its cost of capital, averaging just -15.5% ROIC.
Nuvalent, Inc. capital allocation metrics are N/A for the decade; share count and net debt history are incomplete.
Benjamin Graham lens
Nuvalent, Inc. is evaluated under Benjamin Graham's defensive framework using SEC EDGAR fundamentals using an 8.5 + 2g earnings multiple and a 5.1% AAA bond-yield baseline.